OSCR Oscar Health, Inc. Class A Common Stock

NYSE · Insurance · عرض على SEC EDGAR ↗
$31,51
السعر · أغسطس 19, 2026
البيانات الأساسية اعتبارًا من أغسطس 7, 2026

حول Oscar Health, Inc. Class A Common Stock نظرة عامة على الشركة من ويكيبيديا

Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.

اقرأ المزيد

Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.

History

2012–2015

According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Joshua and his brother Jared owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.

2016

Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".

In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."

2017

On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.

On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.

A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Joshua's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.

While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.

2020–present

In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."

As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."

Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.

Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.

Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO. [1]

In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.

Marketing and brand

Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".

In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.

In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.

Finances

Funding

Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.

During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.

During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.

In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.

During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.

In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.

Revenue

In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.

Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."

By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.

In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.

In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.

In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.

In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.

Headquarters and offices

Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.

المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗

Wikidata ↗

OSCR لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا

السعر
$31.51
القيمة السوقية
P/E (TTM)
-8.5
ربح السهم (آخر 12 شهرًا)
$-1.69
الإيرادات (آخر 12 شهرًا)
$11.70B
عائد التوزيعات
ROE
-44.5%
D/E الدين/حقوق الملكية
0.4
نطاق 52 أسبوعًا
$11 – $33

OSCR مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك

أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم

الإيرادات وصافي الدخل $11.70B
7-point trend, +2296.9%
2019-12-31 2025-12-31
ربح السهم $-1.69
7-point trend, +81.3%
2019-12-31 2025-12-31
التدفق النقدي الحر $1.06B
4-point trend, +609.8%
2021-12-31 2025-12-31
الهوامش -3.8%

التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟

المقياس
اتجاه 5 سنوات
OSCR
متوسط الأقران
P/E (TTM)
5-point trend, -246.6%
-8.5
13.5

الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)

المقياس
اتجاه 5 سنوات
OSCR
متوسط الأقران
Operating Margin (هامش التشغيل)
4-point trend, +88.6%
-3.4%
Net Profit Margin (هامش صافي الربح)
4-point trend, +87.8%
-3.8%
5.4%
ROA (العائد على الأصول)
4-point trend, +61.2%
-7.9%
0.55%
ROE
4-point trend, -21.3%
-44.5%
8.0%
ROIC
4-point trend, +27.4%
-28.5%

الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية

المقياس
اتجاه 5 سنوات
OSCR
متوسط الأقران
Debt / Equity (الدين / حقوق الملكية)
4-point trend, +0.44
0.4
Current Ratio (النسبة الحالية)
4-point trend, -23.8%
0.9
0.1
Quick Ratio (النسبة السريعة)
4-point trend, -4.3%
0.6

النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)

المقياس
اتجاه 5 سنوات
OSCR
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
5-point trend, +536.4%
27.5%
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
5-point trend, +536.4%
43.5%
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
5-point trend, +536.4%
90.8%

مقاييس للسهم ربحية السهم (EPS)، القيمة الدفترية للسهم، التدفق النقدي للسهم، توزيعات الأرباح للسهم

المقياس
اتجاه 5 سنوات
OSCR
متوسط الأقران
EPS (Diluted) (ربحية السهم (مخففة))
5-point trend, +47.2%
$-1.69

كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات

المقياس
اتجاه 5 سنوات
OSCR
متوسط الأقران

OSCR توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود

شراء 19 محللين
  • شراء قوي 2 10,5%
  • شراء 7 36,8%
  • احتفاظ 9 47,4%
  • بيع 1 5,3%
  • بيع قوي 0 0,0%

السعر المستهدف لمدة 12 شهرًا

10 محللين · 2026-08-15
السعر المستهدف الوسيط $28.50 -9,6%
السعر المستهدف المتوسط $29.00 -8,0%

سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي

متوسط المفاجأة
0.16%
الفترة EPS Actual EPS المتوقع المفاجأة
30 يونيو، 2026 $1.10 $0.39 0.71%
31 مارس، 2026 $2.07 $1.21 0.86%
31 ديسمبر، 2025 $-1.24 $-0.91 -0.33%
30 سبتمبر، 2025 $-0.53 $-0.57 0.04%
30 يونيو، 2025 $-0.89 $-0.47 -0.42%
31 مارس، 2025 $0.92 $0.81 0.11%

مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع

الرمز القيمة السوقية P/E الإيرادات سنويًا هامش الربح الصافي ROE هامش الربح الإجمالي
OSCR -8.5 27.5% -3.8% -44.5%
PRU
PFG $19.18B 16.8 -3.1% 7.6% 10.3%
UNM
GL $12.90B 9.9 3.7% 19.4% 20.4%
PRI $8.22B 11.3 6.6% 22.8% 31.9%
LNC $8.46B 7.6 -1.2% 6.5% 12.3%
CNO $4.01B 18.5 0.85% 5.1% 8.9%
GNW $3.54B 16.7 0.08% 3.0% 2.6%

الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي

قائمة الدخل 13
بيانات قائمة الدخل السنوية لـ OSCR
المقياس اتجاه 202520242023202220212020
Revenue 6-point trend, +2428.4% $11.70B $9.18B $5.86B $3.96B $1.84B $463M
SG&A Expense 6-point trend, +1130.0% $2.05B $1.76B $1.43B $1.26B $265M $167M
Operating Income 6-point trend, +1.5% $-396M $57M $-236M $-590M $-544M $-402M
Interest Expense 4-point trend, +600.1% · · $25M $23M $5M $4M
Other Non-op 5-point trend, -1843.3% $-23M $-105.0K $-7M $2M $-1M ·
Pretax Income 6-point trend, -7.8% $-437M $33M $-267M $-610M $-571M $-406M
Income Tax 6-point trend, +436.5% $6M $7M $3M $-523.0K $846.0K $1M
Net Income 6-point trend, -8.9% $-443M $25M $-271M $-606M $-573M $-407M
EPS (Basic) 6-point trend, +88.1% $-1.69 $0.11 $-1.22 $-2.85 $-3.20 $-14.16
EPS (Diluted) 6-point trend, +88.1% $-1.69 $0.10 $-1.22 $-2.85 $-3.20 $-14.16
Shares (Basic) 6-point trend, +796.6% 262,388,000 240,386,000 221,655,000 212,475,000 178,967,056 29,263,424
Shares (Diluted) 6-point trend, +796.6% 262,388,000 265,853,000 221,655,000 212,475,000 178,967,056 29,263,424
EBITDA 4-point trend, +30.7% $-367M $89M $-205M · $-530M ·
الميزانية العمومية 23
بيانات الميزانية العمومية السنوية لـ OSCR
المقياس اتجاه 202520242023202220212020
Cash & Equivalents 6-point trend, +235.7% $2.77B $1.53B $1.87B $1.56B $1.10B $826M
Short-term Investments 2-point trend, -9.5% · $624M $690M · · ·
Receivables $363M · · · · ·
Other Current Assets 5-point trend, +543.3% $24M $21M $7M $6M $4M ·
Current Assets 6-point trend, +146.6% $4.61B $2.85B $3.06B $4.12B $2.31B $1.87B
PP&E (Net) 6-point trend, +146.7% $88M $67M $62M $60M $47M $36M
PP&E (Gross) 6-point trend, +263.3% $230M $181M $150M $117M $89M $63M
Accum. Depreciation 6-point trend, +415.1% $142M $114M $88M $57M $42M $27M
Other Non-current Assets 6-point trend, +811.4% $120M $82M $83M $95M $97M $13M
Total Assets 6-point trend, +178.4% $6.33B $4.84B $3.60B $4.53B $3.32B $2.27B
Accounts Payable 6-point trend, +268.9% $507M $432M $273M $298M $235M $138M
Current Liabilities 6-point trend, +191.9% $4.86B $3.46B $2.43B $3.26B $1.85B $1.67B
Capital Leases 5-point trend, -32.3% $52M $61M $67M $72M $77M ·
Other Non-current Liabilities 6-point trend, +51994000.00 $52M $61M $68M $72M $77M $0
Total Liabilities 6-point trend, +193.2% $5.34B $3.82B $2.80B $3.63B $1.93B $1.82B
Total Debt 4-point trend, +430095000.00 $430M $300M $299M · $0 ·
Common Stock · · · · · $2.0K
Paid-in Capital 6-point trend, +3094.6% $4.26B $3.87B $3.68B $3.51B $3.39B $133M
Retained Earnings 6-point trend, -130.8% $-3.29B $-2.85B $-2.88B $-2.61B $-2.00B $-1.43B
Treasury Stock Flat — no change across 6 periods $3M $3M $3M $3M $3M $3M
AOCI 6-point trend, +1951.2% $18M $-2M $1M $-10M $-4M $879.0K
Stockholders' Equity 6-point trend, +175.4% $978M $1.01B $804M $890M $1.39B $-1.30B
Liabilities + Equity 6-point trend, +178.4% $6.33B $4.84B $3.60B $4.53B $3.32B $2.27B
التدفق النقدي 16
بيانات التدفق النقدي السنوية لـ OSCR
المقياس اتجاه 202520242023202220212020
D&A 6-point trend, +156.0% $29M $32M $31M $15M $15M $11M
Stock-based Comp 6-point trend, +144.4% $88M $110M $160M $112M $86M $36M
Deferred Tax 6-point trend, +3755.2% $2M $-2M $58.0K $-165.0K $-101.0K $-67.0K
Other Non-cash 4-point trend, +389.2% $1.42B $813M $-192M · $290M ·
Operating Cash Flow 6-point trend, +391.6% $1.09B $978M $-272M $380M $-182M $223M
CapEx 6-point trend, +159.4% $36M $28M $26M $29M $26M $14M
Investing Cash Flow 6-point trend, +30.1% $-241M $-1.39B $577M $-227M $-775M $-345M
Debt Issued 6-point trend, +178.9% $410M $0 $0 $305M $0 $147M
Net Debt Issued 3-point trend, +410000000.00 $410M $0 $0 · · ·
Stock Repurchased Flat — no change across 2 periods · · · · $0 $0
Net Stock Activity · · · · $0 ·
Financing Cash Flow 6-point trend, -34.7% $399M $68M $6M $301M $1.24B $612M
Net Change in Cash 6-point trend, +155.9% $1.25B $-341M $311M $455M $282M $490M
Taxes Paid 6-point trend, +1048.6% $18M $674.0K $2M $2M $697.0K $2M
Free Cash Flow 4-point trend, +609.8% $1.06B $950M $-298M · $-208M ·
Levered FCF 2-point trend, -51.9% · · $-323M · $-212M ·
الربحية 7
بيانات الربحية السنوية لـ OSCR
المقياس اتجاه 202520242023202220212020
Operating Margin 4-point trend, +88.6% -3.4% 0.62% -4.0% · -29.6% ·
Net Margin 4-point trend, +87.8% -3.8% 0.28% -4.6% · -31.1% ·
Pretax Margin 4-point trend, +87.9% -3.7% 0.36% -4.6% · -31.0% ·
EBITDA Margin 4-point trend, +89.1% -3.1% 0.97% -3.5% · -28.8% ·
ROA 4-point trend, +61.2% -7.9% 0.60% -6.7% · -20.5% ·
ROE 4-point trend, -21.3% -44.5% 2.8% -32.0% · -36.7% ·
ROIC 4-point trend, +27.4% -28.5% 3.4% -21.6% · -39.3% ·
السيولة والملاءة 5
بيانات السيولة والملاءة السنوية لـ OSCR
المقياس اتجاه 202520242023202220212020
Current Ratio 4-point trend, -23.8% 0.9 0.8 1.3 · 1.2 ·
Quick Ratio 4-point trend, -4.3% 0.6 0.6 0.8 · 0.6 ·
Debt / Equity 4-point trend, +0.44 0.4 0.3 0.4 · 0.0 ·
LT Debt / Equity 4-point trend, +0.44 0.4 0.3 0.4 · 0.0 ·
Interest Coverage 2-point trend, +91.7% · · -9.6 · -115.4 ·
الكفاءة 1
بيانات الكفاءة السنوية لـ OSCR
المقياس اتجاه 202520242023202220212020
Asset Turnover 4-point trend, +218.8% 2.1 2.2 1.4 · 0.7 ·
لكل سهم 3
بيانات لكل سهم السنوية لـ OSCR
المقياس اتجاه 202520242023202220212020
Revenue / Share 4-point trend, +334.1% $44.60 $34.52 $26.45 · $10.27 ·
Cash Flow / Share 4-point trend, +510.9% $4.17 $3.68 $-1.23 · $-1.02 ·
EPS (TTM) 5-point trend, +47.2% $-1.69 $0.10 $-1.22 $-2.85 $-3.20 ·
معدلات النمو 3
بيانات معدلات النمو السنوية لـ OSCR
المقياس اتجاه 202520242023202220212020
Revenue YoY 5-point trend, -90.8% 27.5% 56.5% 47.9% 115.6% 297.3% ·
Revenue CAGR 3Y 3-point trend, -67.4% 43.5% 70.9% 133.1% · · ·
Revenue CAGR 5Y 90.8% · · · · ·
التقييم (آخر 12 شهرًا) 4
بيانات التقييم (آخر 12 شهرًا) السنوية لـ OSCR
المقياس اتجاه 202520242023202220212020
Revenue TTM 5-point trend, +536.4% $11.70B $9.18B $5.86B $3.96B $1.84B ·
Net Income TTM 5-point trend, +22.6% $-443M $25M $-271M $-606M $-573M ·
P/E 5-point trend, -246.6% -8.5 134.4 -7.5 -0.9 -2.5 ·
Earnings Yield 5-point trend, +71.1% -11.8% 0.74% -13.3% -115.9% -40.8% ·

القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات

قائمة الدخل
2025-12-312024-12-312023-12-312022-12-312021-12-31
الإيرادات $11.70B$9.18B$5.86B$3.96B$1.84B
هامش الربح التشغيلي % -3.4%0.62%-4.0%-29.6%
صافي الدخل $-443M$25M$-271M$-606M$-573M
EPS المخفف $-1.69$0.10$-1.22$-2.85$-3.20
الميزانية العمومية
2025-12-312024-12-312023-12-312022-12-312021-12-31
الدين / حقوق الملكية 0.40.30.40.0
النسبة الحالية 0.90.81.31.2
النسبة السريعة 0.60.60.80.6
التدفق النقدي
2025-12-312024-12-312023-12-312022-12-312021-12-31
التدفق النقدي الحر $1.06B$950M$-298M$-208M

آخر الأخبار أحدث العناوين التي تذكر هذه الشركة

مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة

📊

اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.

يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.

الملاك المؤسسيون (13F) 462 مقدمي إقرار · $4.5B إجمالي · حتى تاريخ 30 يونيو، 2026

المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.

النشاط المؤسسي — Q2 2026 مقابل الربع السابق
مراكز جديدة المراكز الخارجة زيادة انخفض صافي التغير في الأسهم
133 (+65 مقابل الربع السابق) 45 (-20 مقابل الربع السابق) 140 (+17 مقابل الربع السابق) 107 (-3 مقابل الربع السابق) +39.9M

مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.

مؤسسة القيمة الأسهم % من 13F المتتبعة النوع
VANGUARD PORTFOLIO MANAGEMENT LLC $314559172 11029424 7,02% الأسهم
VANGUARD CAPITAL MANAGEMENT LLC $301725543 10579437 6,73% الأسهم
D. E. Shaw & Co., Inc. $259880743 9112228 5,80% الأسهم
AMERICAN CENTURY COMPANIES INC $258255502 9055242 5,76% الأسهم
Thrive Capital Management, LLC $180919957 6343617 4,04% الأسهم
STATE STREET CORP $165454531 5801351 3,69% الأسهم
SUSQUEHANNA INTERNATIONAL GROUP, LLP $162917648 5712400 3,64% عقد خيار الشراء
GEODE CAPITAL MANAGEMENT, LLC $141980956 4977203 3,17% الأسهم
FMR LLC $138622458 4860535 3,09% الأسهم
TWO SIGMA INVESTMENTS, LP $115097850 4035689 2,57% الأسهم
BIT Capital GmbH $97480134 3417957 2,18% الأسهم
DIMENSIONAL FUND ADVISORS LP $94434740 3311177 2,11% الأسهم
RENAISSANCE TECHNOLOGIES LLC $93673940 3284500 2,09% الأسهم
JACOBS LEVY EQUITY MANAGEMENT, INC $86282012 3025316 1,93% الأسهم
JANE STREET GROUP, LLC $74631792 2616823 1,67% الأسهم
GLYNN CAPITAL MANAGEMENT LLC $73462615 2575828 1,64% الأسهم
CITADEL ADVISORS LLC $72469320 2541000 1,62% عقد خيار الشراء
WOLVERINE ASSET MANAGEMENT LLC $61825656 2167800 1,38% عقد خيار البيع
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60458493 2119863 1,35% الأسهم
SUSQUEHANNA INTERNATIONAL GROUP, LLP $55351616 1940800 1,24% عقد خيار البيع
JANE STREET GROUP, LLC $53968396 1892300 1,20% عقد خيار الشراء
BlackBarn Capital Partners LP $49910000 1750000 1,11% عقد خيار البيع
BNP PARIBAS FINANCIAL MARKETS $48660710 1706196 1,09% الأسهم
VANGUARD FIDUCIARY TRUST CO $45996029 1612764 1,03% الأسهم
CITADEL ADVISORS LLC $44459828 1558900 0,99% عقد خيار البيع
STATE OF MICHIGAN RETIREMENT SYSTEM $41354000 1450000 0,92% الأسهم
BANK OF AMERICA CORP /DE/ $36176793 1268471 0,81% الأسهم
Assenagon Asset Management S.A. $35592732 1247992 0,79% الأسهم
TWO SIGMA ADVISERS, LP $35534136 2472800 0,79% الأسهم
JANE STREET GROUP, LLC $33796200 1185000 0,75% عقد خيار البيع
GROUP ONE TRADING LLC $32744154 1148112 0,73% الأسهم
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $31200652 1093992 0,70% الأسهم
Qube Research & Technologies Ltd $30913940 1083939 0,69% الأسهم
TUDOR INVESTMENT CORP ET AL $29055948 1018792 0,65% الأسهم
GILDER GAGNON HOWE & CO LLC $28576515 1001982 0,64% الأسهم
GOLDMAN SACHS GROUP INC $26322819 922960 0,59% الأسهم
Walleye Capital LLC $23243058 814974 0,52% الأسهم
Point72 Asset Management, L.P. $22809212 799762 0,51% الأسهم
Walleye Trading LLC $22744700 797500 0,51% عقد خيار الشراء
FEDERATED HERMES, INC. $22241550 779858 0,50% الأسهم
Walleye Trading LLC $20594292 722100 0,46% عقد خيار البيع
Balyasny Asset Management L.P. $20211240 708669 0,45% الأسهم
WOLVERINE TRADING, LLC $19244780 1006000 0,43% عقد خيار الشراء
MILLENNIUM MANAGEMENT LLC $18292101 641378 0,41% الأسهم
Halter Ferguson Financial Inc. $17882240 627007 0,40% الأسهم
CITADEL ADVISORS LLC $17044921 597648 0,38% الأسهم
Walleye Trading LLC $15952833 559356 0,36% الأسهم
Caption Management, LLC $15723076 551300 0,35% عقد خيار البيع
WOLVERINE TRADING, LLC $14846793 776100 0,33% عقد خيار البيع
CAPITAL FUND MANAGEMENT S.A. $14807327 519191 0,33% الأسهم
PFM Health Sciences, LP $14802336 519016 0,33% الأسهم
CANADA PENSION PLAN INVESTMENT BOARD $14317040 502000 0,32% الأسهم
WELLS FARGO & COMPANY/MN $14301981 501472 0,32% الأسهم
Eurizon Capital SGR S.p.A. $13987854 490380 0,31% الأسهم
RPG Investment Advisory, LLC $13981017 490218 0,31% الأسهم
TUDOR INVESTMENT CORP ET AL $13977652 490100 0,31% عقد خيار الشراء
Caption Management, LLC $13769456 482800 0,31% عقد خيار الشراء
Alphabet Inc. $13746298 481988 0,31% الأسهم
Swiss National Bank $13501368 473400 0,30% الأسهم
CREDIT AGRICOLE S A $13119286 460003 0,29% الأسهم
RBF Capital, LLC $12822706 449604 0,29% الأسهم
MILLENNIUM MANAGEMENT LLC $12802628 448900 0,29% عقد خيار البيع
Trexquant Investment LP $12674259 444399 0,28% الأسهم
BlackRock, Inc. $12343114 432788 0,28% الأسهم
IMC-Chicago, LLC $12036581 422040 0,27% الأسهم
FORA Capital, LLC $11957021 419030 0,27% الأسهم
PERCEPTIVE ADVISORS LLC $11408000 400000 0,25% الأسهم
Connor, Clark & Lunn Investment Management Ltd. $11327203 397167 0,25% الأسهم
Rhenman & Partners Asset Management AB $11179840 392000 0,25% الأسهم
SILVERCREST ASSET MANAGEMENT GROUP LLC $10799925 378679 0,24% الأسهم
UBS Group AG $10607358 371927 0,24% الأسهم
WELLINGTON MANAGEMENT GROUP LLP $10027661 351601 0,22% الأسهم
ARDSLEY ADVISORY PARTNERS LP $9982000 350000 0,22% الأسهم
VICTORY CAPITAL MANAGEMENT INC $9924475 347983 0,22% الأسهم
Fiduciary Alliance LLC $9802210 343696 0,22% الأسهم
BCS Private Wealth Management, Inc. $9665000 338885 0,22% الأسهم
SIMPLEX TRADING, LLC $9283516 325509 0,21% الأسهم
Squarepoint Ops LLC $9166214 321396 0,20% الأسهم
SEB Asset Management AB $9085456 318565 0,20% الأسهم
MARSHALL WACE, LLP $9052762 317418 0,20% الأسهم
Squarepoint Ops LLC $8906796 312300 0,20% عقد خيار الشراء
BARCLAYS PLC $8827711 309527 0,20% الأسهم
Engineers Gate Manager LP $8802185 308632 0,20% الأسهم
TOWLE & CO $8801186 308597 0,20% الأسهم
RHUMBLINE ADVISERS $8563598 300267 0,19% الأسهم
PRUDENTIAL FINANCIAL INC $8412544 294970 0,19% الأسهم
FIRST TRUST ADVISORS LP $8152727 285860 0,18% الأسهم
MILLENNIUM MANAGEMENT LLC $7939968 278400 0,18% عقد خيار الشراء
FRED ALGER MANAGEMENT, LLC $7777290 272696 0,17% الأسهم
TORONTO DOMINION BANK $7632066 267604 0,17% الأسهم
BANK OF MONTREAL /CAN/ $7383828 258900 0,16% عقد خيار البيع
General Equity Holdings LP $6844800 240000 0,15% الأسهم
TD Asset Management Inc $6561311 230060 0,15% الأسهم
VANGUARD ASSET MANAGEMENT, Ltd $6509690 228250 0,15% الأسهم
OSAIC HOLDINGS, INC. $6398318 224346 0,14% الأسهم
AMERIPRISE FINANCIAL INC $6363383 223120 0,14% الأسهم
Squarepoint Ops LLC $6203100 217500 0,14% عقد خيار البيع
Public Sector Pension Investment Board $6120392 214600 0,14% الأسهم
Bridgewater Associates, LP $6094838 213704 0,14% الأسهم
NORGES BANK $5741390 201311 0,13% الأسهم

المطلعون على الشركة 21 من المطلعين · مسؤولون 10 · مديرون 12

مطلع الدور آخر نشاط الأسهم المملوكة مشتريات 12 شهرًا مبيعات 12 شهرًا صافي 12 شهرًا
Mark T Bertolini Chief Executive Officer 30 يونيو، 2026 S 7751570 1 8 $-58759399
Richard Scott Blackley Chief Financial Officer 2 يونيو، 2026 S 1074977 0 1 $-493628
Janet Liang President, Oscar Insurance 2 يونيو، 2026 S 259057 0 1 $-194356
Meghan V. Joyce Chief Operating Officer 1 سبتمبر، 2021 M 34669 0 0 $0
Victoria Baltrus Chief Accounting Officer 2 يونيو، 2026 S 214589 0 1 $-23718
Adam Mcananey Chief Legal Officer 2 يونيو، 2026 S 218096 0 1 $-153593
Joshua Kushner Co-Founder and Vice Chairman 21 نوفمبر، 2024 P 6343617 0 0 $0
Dennis Weaver Chief Clinical Officer 1 سبتمبر، 2021 M 5323 0 0 $0
Alessandrea C. Quane EVP, Chief Insurance Officer 31 أغسطس، 2021 A 0 0 $0
Joel Klein Chief Policy & Strat. Officer 5 مارس، 2021 A 0 0 0 $0
William Gassen مدير 9 يوليو، 2026 A 82840 0 0 $0
David Plouffe مدير 9 يوليو، 2026 A 137121 0 0 $0
Sid Sankaran مدير 9 يوليو، 2026 A 22609 0 0 $0
Mario Schlosser مدير 1 يوليو، 2026 C 0 0 16 $-32199014
Laura W Lang مدير 4 يونيو، 2026 A 82840 0 0 $0
Vanessa Ames Wittman مدير 4 يونيو، 2026 A 137121 0 0 $0
Jeffery H Boyd مدير 9 إبريل، 2026 A 0 0 $0
Elbert O. Robinson Jr. مدير 5 مارس، 2021 A 50000 0 0 $0
Teri List-Stoll مدير 5 مارس، 2021 A 50000 0 0 $0
Jr Charles E Phillips مدير 5 مارس، 2021 A 50000 0 0 $0
Ari Fischel 5 مارس، 2021 A 0 0 0 $0

المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط

الناشطون والمالكون بنسبة 5%+ 1 حيازة

المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.

مقدم مقدم حصة الحالة الغرض إيداع
Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 إيداعات 13 نوفمبر، 2024 إيداع أولي SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 65 صناديق مؤشرات متداولة

الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.

صندوق الوزن الوحدات حتى تاريخ المصدر
HEAL · Global X Funds 4,61% 51902 NS 31 مايو، 2026 N-PORT
ABLS · Abacus FCF ETF Trust 3,73% 2476 NS 30 إبريل، 2026 N-PORT
CBLS · Elevation Series Trust 2,79% 80448 NS 30 إبريل، 2026 N-PORT
CBSE · Elevation Series Trust 2,79% 72369 NS 30 إبريل، 2026 N-PORT
PTH · Invesco Exchange-Traded Fund Trust 1,80% 159618 SH 8 أغسطس، 2026 يومي
RNIN · EA Series Trust 1,77% 146523 NS 30 إبريل، 2026 N-PORT
IAK · iShares Trust 0,63% 132150 SH 8 أغسطس، 2026 يومي
AVUV · AMERICAN CENTURY ETF TRUST 0,53% 6454468 NS 31 مايو، 2026 N-PORT
CLSE · Trust for Professional Managers 0,48% 132126 NS 31 مايو، 2026 N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS 0,40% 258034 SH 8 أغسطس، 2026 يومي
IWO · iShares Trust 0,40% 2189278 SH 8 أغسطس، 2026 يومي
DWAS · Invesco Exchange-Traded Fund Trust … 0,37% 59569 SH 8 أغسطس، 2026 يومي
OASC · Unified Series Trust 0,25% 9324 NS 31 مايو، 2026 N-PORT
DFVE · DoubleLine ETF Trust 0,22% 5265 NS 31 مارس، 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,21% 1387125 SH 8 أغسطس، 2026 يومي
IWM · iShares Trust 0,20% 6138237 SH 8 أغسطس، 2026 يومي
VBK · VANGUARD INDEX FUNDS 0,19% 3171535 SH 8 أغسطس، 2026 يومي
ISCG · iShares Trust 0,19% 70748 SH 8 أغسطس، 2026 يومي
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,19% 74299 NS 30 إبريل، 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,18% 7801 NS 30 إبريل، 2026 N-PORT
SMLF · iShares Trust 0,18% 282874 SH 8 أغسطس، 2026 يومي
FYC · First Trust Exchange-Traded AlphaDE… 0,18% 99887 NS 30 إبريل، 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,15% 154382 SH 8 أغسطس، 2026 يومي
RSSL · Global X Funds 0,11% 87779 NS 30 إبريل، 2026 N-PORT
ITWO · ProShares Trust 0,11% 9555 NS 31 مايو، 2026 N-PORT
DFAS · Dimensional ETF Trust 0,11% 798894 NS 30 إبريل، 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,10% 1045927 NS 31 مايو، 2026 N-PORT
AVLV · AMERICAN CENTURY ETF TRUST 0,10% 576130 NS 31 مايو، 2026 N-PORT
ISCB · iShares Trust 0,09% 10063 SH 8 أغسطس، 2026 يومي
FYX · First Trust Exchange-Traded AlphaDE… 0,09% 60366 NS 30 إبريل، 2026 N-PORT
ESML · iShares Trust 0,09% 96699 SH 8 أغسطس، 2026 يومي
VB · VANGUARD INDEX FUNDS 0,08% 5488922 SH 8 أغسطس، 2026 يومي
VFH · VANGUARD WORLD FUND 0,08% 384466 SH 8 أغسطس، 2026 يومي
VXF · VANGUARD INDEX FUNDS 0,07% 2534194 SH 8 أغسطس، 2026 يومي
UWM · ProShares Trust 0,07% 7474 NS 31 مايو، 2026 N-PORT
WSML · iShares Trust 0,06% 14478 SH 8 أغسطس، 2026 يومي
URTY · ProShares Trust 0,05% 7563 NS 31 مايو، 2026 N-PORT
AVUQ · AMERICAN CENTURY ETF TRUST 0,05% 5330 NS 31 مايو، 2026 N-PORT
FNCL · FIDELITY COVINGTON TRUST 0,04% 52605 NS 30 إبريل، 2026 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 0,04% 169 NS 31 مايو، 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,04% 9312 NS 30 إبريل، 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0,04% 12030 SH 8 أغسطس، 2026 يومي
TILT · FlexShares Trust 0,03% 38192 NS 30 إبريل، 2026 N-PORT
AVMV · AMERICAN CENTURY ETF TRUST 0,03% 8235 NS 31 مايو، 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,03% 164245 NS 31 مايو، 2026 N-PORT
FNDA · SCHWAB STRATEGIC TRUST 0,03% 103995 NS 31 مايو، 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,02% 7591 NS 31 مايو، 2026 N-PORT
HDG · ProShares Trust 0,02% 190 NS 31 مايو، 2026 N-PORT
DFAC · Dimensional ETF Trust 0,02% 416676 NS 30 إبريل، 2026 N-PORT
DFSU · Dimensional ETF Trust 0,02% 18514 NS 30 إبريل، 2026 N-PORT